Skip to Content

Biotricity Inc BTCY

Morningstar Rating
$1.45 −0.01 (0.68%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BTCY is trading at a 48% discount.
Price
$1.47
Fair Value
$6.60
Uncertainty
Extreme
1-Star Price
$12.57
5-Star Price
$3.38
Economic Moat
Mxnzx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BTCY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.46
Day Range
$1.391.60
52-Week Range
$0.704.45
Bid/Ask
$1.52 / $1.60
Market Cap
$13.73 Mil
Volume/Avg
193,187 / 104,337

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.11
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed, which is a virtual clinic platform that enables clinicians to provide outstanding patient care remotely; Bioheart, which is a personal heart monitor; and Biocare health.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
55

Valuation

Metric
BTCY
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
1.11
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BTCY
Quick Ratio
0.10
Current Ratio
0.21
Interest Coverage
−1.92
Quick Ratio
BTCY

Profitability

Metric
BTCY
Return on Assets (Normalized)
−212.58%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
BTCY
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHgrwxmqRwnkgxj$185.8 Bil
SYK
Stryker CorpYrppsnqbjnBjsks$124.7 Bil
MDT
Medtronic PLCRvktptrcChhtcf$105.2 Bil
BSX
Boston Scientific CorpGzxqvpkmHtgnltp$99.0 Bil
EW
Edwards Lifesciences CorpHhktfnwwmVsdrmc$52.3 Bil
DXCM
DexCom IncNxwwljnvcQjt$52.1 Bil
ZBH
Zimmer Biomet Holdings IncYftdkrrfdMscy$24.8 Bil
ALGN
Align Technology IncZcjxlhnpRhhkcy$22.6 Bil
PHG
Koninklijke Philips NV ADRNtrvmjxLbrxymm$18.5 Bil
PODD
Insulet CorpDzgbsrxpLnldsys$11.5 Bil

Sponsor Center